Argonaute-2 Enhances Suppression of Human Cytomegalovirus Replication by Polycistronic Short Hairpin Rnas Targeting Ul46,Ul70 and Ul122

Abstract

Background

Human cytomegalovirus (HCMV) is a common human pathogen that causes significant morbidity and mortality. The efficacy of anti-HCMV drugs such as ganciclovir, foscarnet and cidofovir is limited because of drug toxicities and frequent development of resistance. Here, we report an alternative anti-HCMV method using RNA silencing.

Methods

Combinatorial use of second-generation short hairpin RNAs (shRNA-miRs) targeting various transcripts of HCMV and an RNA-silencing endonuclease Argonaute-2 (Ago2) expression vector were applied to inhibit replication of HCMV AD169. Normal human fetal lung MRC-5 fibroblasts were transfected with pSM30-shRNA-miRs harbouring single or multiple shRNA-miR cassettes with or without Ago2 and then infected with HCMV AD169. Production of small interfering RNA (siRNA) was quantified by reverse transcription PCR. Virus secretion was evaluated by plaque reduction assays.

Results

The use of shRNA-miRs targeting a single HCMV gene suppressed HCMV AD169 viral titres by 50–70%. Polycistronic shRNA-miRs targeting UL46+UL122 and UL70+UL46+UL122 reached nearly 80% of inhibition. Coexpression of Ago2 with shRNA-miRs targeting UL46+UL122 and UL70+UL46+UL122 achieved a 95% reduction in viral maturation.

Conclusions

Coexpression of Ago2 with shRNA-miRs enhanced the production of mature siRNAs and increased the efficiency of RNA silencing in the suppression of HCMV replication. This strategy may be universally applied to RNA interference-based therapies.

References

Chau

T.N.

, Lau

L.K.

, Lee

K.C.

Association of self-limited cytomegalovirus colitis and shigellosis in an immunocompetent patient. Eur J Gastroenterol Hepatol 1996; 8: 819–822.

Buckner

F.S.

, Pomeroy

Cytomegalovirus disease of the gastrointestinal tract in patients without AIDS. Clin Infect Dis 1993; 17: 644–656.

Meyers

J.D.

, Flournoy

, Thomas

E.D.

Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986; 153: 478–488.

Lischka

, Zimmermann

Antiviral strategies to combat cytomegalovirus infections in transplant recipients. Curr Opin Pharmacol 2008; 8: 541–548.

Randolph-Habecker

, Iwata

, Torok-Storb

Cytomegalovirus mediated myelosuppression. J Clin Virol 2002; 25 Suppl 2: S51–S56.

Mui

T.S.

, Kapp

, Einsele

, Grigoleit

G.U.

T-cell therapy for cytomegalovirus infection. Curr Opin Organ Transplant 2010; 15: 744–750.

P.Y.

, Xie

, Woodle

M.C.

In vivo application of RNA interference: from functional genomics to therapeutics. Adv Genet 2005; 54: 115–142.

Brodersen

, Voinnet

Revisiting the principles of microRNA target recognition and mode of action. Nat Rev Mol Cell Biol 2009; 10: 141–148.

Durcan

, Murphy

, Cryan

S.A.

Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharm 2008; 5: 559–566.

10.

Takeshita

, Ochiya

Therapeutic potential of RNA interference against cancer. Cancer Sci 2006; 97: 689–696.

11.

Chable-Bessia

, Meziane

, Latreille

Suppression of HIV-1 replication by microRNA effectors. Retrovirology 2009; 6: 26.

12.

Schopman

N.C.

, ter Brake

, Berkhout

Anticipating and blocking HIV-1 escape by second generation antiviral shRNAs. Retrovirology 2010; 7: 52.

13.

Yeung

M.L.

, Benkirane

, Jeang

K.T.

Small non-coding RNAs, mammalian cells, and viruses: regulatory interactions?

Retrovirology 2007; 4: 74.

14.

Bennasser

, Yeung

M.L.

, Benkirane

, Jeang

K.T.

RNA interference and HIV-1: hits and misses. Curr Opin HIV AIDS 2006; 1: 208–211.

15.

Svoboda

Off-targeting and other non-specific effects of RNAi experiments in mammalian cells. Curr Opin Mol Ther 2007; 9: 248–257.

16.

Aagaard

, Rossi

J.J.

RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 2007; 59: 75–86.

17.

Chang

, Elledge

S.J.

, Hannon

G.J.

Lessons from nature: microRNA-based shRNA libraries. Nat Methods 2006; 3: 707–714.

18.

Paddison

P.J.

, Cleary

, Silva

J.M.

Cloning of short hairpin RNAs for gene knockdown in mammalian cells. Nat Methods 2004; 1: 163–167.

19.

van de Wetering

, Oving

, Muncan

Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 2003; 4: 609–615.

20.

Kim

V.N.

, Han

, Siomi

M.C.

Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126–139.

21.

Winter

, Jung

, Keller

, Gregory

R.I.

, Diederichs

Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 2009; 11: 228–234.

22.

, Yonekubo

, Zeng

, Osisami

, Frohman

M.A.

Design of expression vectors for RNA interference based on miRNAs and RNA splicing. FEBS J 2006; 273: 5421–5427.

23.

Chiba

, Striker

R.L.

Jr. . yesh-Melnick M. Microculture plaque assay for human and simian cytomegaloviruses. Appl Microbiol 1972; 23: 780–783.

24.

Scalzo

A.A.

, Fitzgerald

N.A.

, Simmons

, La Vista

A.B.

, Shellam

G.R.

Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen. J Exp Med 1990; 171: 1469–1483.

25.

Wiebusch

, Hagemeier

The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J 2001; 20: 1086–1098.

26.

Gatignol

, Buckler-White

, Berkhout

, Jeang

K.T.

Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 1991; 251: 1597–1600.

27.

Meister

, Landthaler

, Patkaniowska

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol Cell 2004; 15: 185–197.

28.

Silva

J.M.

, Li

M.Z.

, Chang

Second-generation shRNA libraries covering the mouse and human genomes. Nat Genet 2005; 37: 1281–1288.

29.

Zuker

Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 2003; 31: 3406–3415.

30.

Mathews

D.H.

, Sabina

, Zuker

, Turner

D.H.

Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 1999; 288: 911–940.

31.

, Ilves

, Dallas

Minimal-length short hairpin RNAs: the relationship of structure and RNAi activity. RNA 2010; 16: 106–117.

32.

Shao

, Chan

C.Y.

, Maliyekkel

Effect of target secondary structure on RNAi efficiency. RNA 2007; 13: 1631–1640.

33.

Westerhout

E.M.

, Ooms

, Vink

, Das

A.T.

, Berkhout

HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res 2005; 33: 796–804.

34.

Diederichs

, Jung

, Rothenberg

S.M.

Coexpression of Argonaute-2 enhances RNA interference toward perfect match binding sites. Proc Natl Acad Sci U S A 2008; 105: 9284–9289.

35.

Grimm

, Wang

, Lee

J.S.

Argonaute proteins are key determinants of RNAi efficacy, toxicity, and persistence in the adult mouse liver. J Clin Invest 2010; 120: 3106–3119.

36.

Chendrimada

T.P.

, Gregory

R.I.

, Kumaraswamy

TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 2005; 436: 740–744.

37.

Wang

H.W.

, Noland

, Siridechadilok

Structural insights into RNA processing by the human RISC-loading complex. Nat Struct Mol Biol 2009; 16: 1148–1153.

38.

Wiebusch

, Truss

, Hagemeier

Inhibition of human cytomegalovirus replication by small interfering RNAs. J Gen Virol 2004; 85: 179–184.

39.

Yue

, Sheng

, Ren

, Penmatsa

A miR-21 hairpin structure-based gene knockdown vector. Biochem Biophys Res Commun 2010; 394: 667–672.

40.

Lau

P.W.

, Potter

C.S.

, Carragher

, MacRae

I.J.

Structure of the human Dicer-TRBP complex by electron microscopy. Structure 2009; 17: 1326–1332.

41.

Cifuentes

, Xue

, Taylor

D.W.

A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science 2010; 328: 1694–1698.

42.

Grimm

, Kay

M.A.

Combinatorial RNAi: a winning strategy for the race against evolving targets?

Mol Ther 2007; 15: 878–888.

43.

Grimm

, Kay

M.A.

Combinatorial RNAi: a winning strategy for the race against evolving targets?

Mol Ther 2007; 15: 878–888.

44.

Liu

Y.P.

, Haasnoot

, Berkhout

Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Res 2007; 35: 5683–5693.

45.

Saayman

, Barichievy

, Capovilla

The efficacy of generating three independent anti-HIV-1 siRNAs from a single U6 RNA Pol III-expressed long hairpin RNA. PLoS ONE 2008; 3: e2602.

46.

Liu

Y.P.

, Haasnoot

ter BO, Berkhout B, Konstantinova P. Inhibition of HIV-1 by multiple siRNAs expressed from a single microRNA polycistron. Nucleic Acids Res 2008; 36: 2811–2824.

47.

Chattopadhyay

, Ely

, Bloom

, Weinberg

M.S.

, Arbuthnot

Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles. Biochem Biophys Res Commun 2009; 389: 484–489.

48.

Saayman

, Arbuthnot

, Weinberg

M.S.

Deriving four functional anti-HIV siRNAs from a single Pol III-generated transcript comprising two adjacent long hairpin RNA precursors. Nucleic Acids Res 2010; 38: 6652–6663.

49.

ter Brake

, 't Hooft

, Liu

Y.P.

, Centlivre

, von Eije

K.J.

, Berkhout

Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. Mol Ther 2008; 16: 557–564.